Fact CheckerSign in

NCT04643106Recruiting

Comparison of Hemostatic Agent to Suture in Terms of Hemostatic Function and Preservation of Ovarian Function

A Multi-center, Randomized, Investigator-initiated Trial to Evaluate the Efficacy of PRreservation of ovArian Function, Hemostasis, and sAfety of a Hemostatic Agent Versus Suturing During Laparoscopic Ovarian Cystectomy for Endometrioma

Source: ClinicalTrials.gov · Last updated 26 Jun 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

This study aims to evaluate the efficacy of preservation of ovarian function, hemostasis, and safety of a hemostatic agent versus suturing during laparoscopic ovarian cystectomy for ovarian endometriosis.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
90 (estimated)
First submitted
1 Nov 2020
Start date
25 Feb 2021
Primary completion date
31 Dec 2025
Lead sponsor
Seoul National University Hospital
NCT number
NCT04643106

What you commit to

  • Study type: Interventional
  • Planned participants: 90
  • From 25 Feb 2021 to the primary completion date, 31 Dec 2025
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Hormonal therapy within recent 3 months

Other illness

  • Suspicious disease of ovarian malignancy

Lab values

  • Lower than 0.05 ng/ml of serum Anti-mullerian hormone level

Age

  • Age: 18 and younger, 46 and older

Other

  • No 'ovarian' endometriosis
  • Pregnancy or breastfeeding.
  • Considered as inappropriate by the researcher's judgment.

Who the study is looking for

  • Informed consent.
  • Age: 19-45 year-old women
  • American Society of Anesthesiologists Physical Status classification 1 or 2
  • Plan of laparoscopic ovarian cystectomy for unilateral or bilateral ovarian endometriosis diagnosed by ultrasonography
  • Regular menstruation every 21-45 days

Age in the registry: 19 years to 45 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Dongguk University Ilsan Hospital
Coordinator of this site? Confirm its status
Goyang-siSouth KoreaNot yet recruiting
Seoul National University Hospital
Coordinator of this site? Confirm its status
SeoulSouth KoreaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.